Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ACITRETIN (FORM I), with a corresponding US DMF Number 24430.
Remarkably, this DMF maintains an Active status since its submission on November 11, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 10, 2016, and payment made on July 01, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II